Serum phosphate optimal timing and range associated with patients survival in haemodialysis: The COSMOS study

dc.creatorFernández-Martín J.L.
dc.creatorDusso A.
dc.creatorMartínez-Camblor P.
dc.creatorDionisi M.P.
dc.creatorFloege J.
dc.creatorKetteler M.
dc.creatorLondon G.
dc.creatorLocatelli F.
dc.creatorGórriz J.L.
dc.creatorRutkowski B.
dc.creatorBos W.-J.
dc.creatorTielemans C.
dc.creatorMartin P.-Y.
dc.creatorWüthrich R.P.
dc.creatorPavlovic D.
dc.creatorBenedik M.
dc.creatorRodríguez-Puyol D.
dc.creatorCarrero J.J.
dc.creatorZoccali C.
dc.creatorCannata-Andía J.B.
dc.creatorCovic A.
dc.creatorFerreira A.
dc.creatorGoldsmith D.
dc.creatorKramar R.
dc.creatorMemmos D.
dc.creatorNagy J.
dc.creatorTeplan V.
dc.creatorVerbeelen D.
dc.creatorMotellón J.L.
dc.creatorTurner M.
dc.creatorChaussy J.
dc.creatorMolemans B.
dc.creatorZani W.
dc.creatorRosser D.
dc.creatorDehmel B.
dc.creatorFouqueray B.
dc.creatorBradbury B.
dc.creatorAcquavella J.
dc.creatorHollowell J.
dc.creatorCarter D.
dc.creatorHolland P.
dc.creatorBaños A.
dc.creatorMattin C.
dc.creatorCritchlow C.
dc.creatorKim J.
dc.creatorLewis C.
dc.creatorPanayi A.
dc.creatorHemetsberger M.
dc.creatorCroft S.
dc.creatorJaeger P.
dc.creatorMuehlebach P.
dc.creatorBlackburn J.
dc.creatorZumsteg E.
dc.creatorRodríguez S.
dc.creatorPérez A.
dc.creatorFaner P.
dc.creatorIzco I.
dc.creatorTraseira S.
dc.creatorCastro C.
dc.creatorMoreno J.
dc.creatorCalle D.
dc.creatorPieraccini F.
dc.date.accessioned2020-09-02T22:17:29Z
dc.date.accessioned2022-11-08T20:18:51Z
dc.date.available2020-09-02T22:17:29Z
dc.date.available2022-11-08T20:18:51Z
dc.date.created2020-09-02T22:17:29Z
dc.date.issued2019
dc.identifier34, 4, 673-681
dc.identifier09310509
dc.identifierhttps://hdl.handle.net/20.500.12728/4454
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5142916
dc.languageen
dc.publisherOxford University Press
dc.subjectcalcaemia
dc.subjectchronic haemodialysis
dc.subjectepidemiology
dc.subjecthyperparathyroidism
dc.subjectphosphataemia
dc.subjectalbumin
dc.subjectbiological marker
dc.subjectcalcium
dc.subjecthemoglobin
dc.subjectparathyroid hormone
dc.subjectphosphate
dc.subjectbiological marker
dc.subjectcalcium
dc.subjectparathyroid hormone
dc.subjectphosphate
dc.subjectadult
dc.subjectalbumin blood level
dc.subjectall cause mortality
dc.subjectArticle
dc.subjectblood sampling
dc.subjectbody mass
dc.subjectcalcium blood level
dc.subjectchronic kidney disease-mineral and bone disorder
dc.subjectclinical assessment
dc.subjectcohort analysis
dc.subjectcomorbidity
dc.subjectfemale
dc.subjecthemodialysis
dc.subjecthemoglobin blood level
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectmortality risk
dc.subjectmulticenter study
dc.subjectobservational study
dc.subjectparathyroid hormone blood level
dc.subjectphosphate blood level
dc.subjectpriority journal
dc.subjectprospective study
dc.subjectblood
dc.subjectchronic kidney disease-mineral and bone disorder
dc.subjectclinical trial
dc.subjecthemodialysis
dc.subjectmortality
dc.subjectprognosis
dc.subjectrandomization
dc.subjectsecondary hyperparathyroidism
dc.subjectsurvival rate
dc.subjectBiomarkers
dc.subjectCalcium
dc.subjectChronic Kidney Disease-Mineral and Bone Disorder
dc.subjectFemale
dc.subjectHumans
dc.subjectHyperparathyroidism, Secondary
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectParathyroid Hormone
dc.subjectPhosphates
dc.subjectPrognosis
dc.subjectProspective Studies
dc.subjectRandom Allocation
dc.subjectRenal Dialysis
dc.subjectSurvival Rate
dc.titleSerum phosphate optimal timing and range associated with patients survival in haemodialysis: The COSMOS study
dc.typeArticle


Este ítem pertenece a la siguiente institución